LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,966,395 | +10.0% | 32,817 | +32.4% | 0.28% | +16.4% |
| Q2 2023 | $1,787,431 | -2.4% | 24,791 | -0.4% | 0.24% | -5.4% |
| Q1 2023 | $1,831,203 | +38.2% | 24,894 | +25.5% | 0.26% | +29.6% |
| Q4 2022 | $1,324,644 | -22.7% | 19,830 | -0.3% | 0.20% | -32.5% |
| Q3 2022 | $1,713,000 | +22.4% | 19,889 | +26.8% | 0.30% | +13.0% |
| Q2 2022 | $1,399,000 | -15.5% | 15,680 | +6.5% | 0.26% | -4.0% |
| Q1 2022 | $1,656,000 | -21.4% | 14,720 | +7.9% | 0.27% | -22.9% |
| Q4 2021 | $2,107,000 | +12.0% | 13,640 | +1.0% | 0.35% | +3.5% |
| Q3 2021 | $1,882,000 | +6.7% | 13,507 | +0.4% | 0.34% | +9.6% |
| Q2 2021 | $1,764,000 | -11.9% | 13,449 | +2.4% | 0.31% | -15.5% |
| Q1 2021 | $2,003,000 | +50.0% | 13,136 | -2.1% | 0.37% | +35.8% |
| Q4 2020 | $1,335,000 | +16.9% | 13,419 | +12.0% | 0.27% | +1.5% |
| Q3 2020 | $1,142,000 | -6.6% | 11,984 | +9.6% | 0.27% | -11.3% |
| Q2 2020 | $1,223,000 | +55.8% | 10,932 | +1.2% | 0.30% | +24.9% |
| Q1 2020 | $785,000 | -34.3% | 10,799 | -5.7% | 0.24% | -11.4% |
| Q4 2019 | $1,194,000 | +5.7% | 11,448 | +0.8% | 0.27% | +1.5% |
| Q3 2019 | $1,130,000 | +1.3% | 11,357 | +16.2% | 0.27% | +0.8% |
| Q2 2019 | $1,116,000 | +19.2% | 9,776 | +41.7% | 0.27% | -5.3% |
| Q4 2018 | $936,000 | -44.7% | 6,897 | +11.7% | 0.28% | -34.2% |
| Q3 2018 | $1,694,000 | +23.0% | 6,172 | -7.2% | 0.43% | +18.9% |
| Q2 2018 | $1,377,000 | +23.1% | 6,648 | -1.9% | 0.36% | +18.9% |
| Q1 2018 | $1,119,000 | +18.8% | 6,774 | -1.5% | 0.30% | +18.0% |
| Q4 2017 | $942,000 | +0.3% | 6,877 | -0.3% | 0.26% | -3.0% |
| Q3 2017 | $939,000 | +12.5% | 6,898 | +0.3% | 0.26% | +8.2% |
| Q2 2017 | $835,000 | +13.9% | 6,877 | -0.7% | 0.24% | +13.5% |
| Q1 2017 | $733,000 | +6.5% | 6,928 | +2.3% | 0.22% | +3.4% |
| Q4 2016 | $688,000 | +5.7% | 6,775 | -0.5% | 0.21% | +1.0% |
| Q3 2016 | $651,000 | -19.1% | 6,807 | +0.9% | 0.21% | -22.3% |
| Q2 2016 | $805,000 | +7.5% | 6,746 | -3.6% | 0.26% | +6.0% |
| Q1 2016 | $749,000 | -1.1% | 6,996 | +0.2% | 0.25% | -5.3% |
| Q4 2015 | $757,000 | +124.6% | 6,985 | +77.7% | 0.26% | +112.9% |
| Q3 2015 | $337,000 | -14.5% | 3,930 | +0.7% | 0.12% | -4.6% |
| Q2 2015 | $394,000 | – | 3,901 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |